Latest News about ADAP
Recent news which mentions ADAP
From Motley Fool
From Benzinga
Adaptimmune Therapeutics Q1 2022 Earnings Conference Call On May 9, 2022 At 08:00 AM ET
May 04, 2022
Tickers
ADAP
From Benzinga
From Motley Fool
Why Adaptimmune Therapeutics Shares Dropped 14.7% on Monday
April 11, 2022
Tickers
ADAP
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 15, 2022
From Benzinga
Earnings Scheduled For March 14, 2022
March 14, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 21, 2022
From Benzinga
2 Cancer Stocks With Absurdly Low Valuations
January 19, 2022
From Motley Fool
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
From Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
From Motley Fool
Why Adaptimmune Therapeutics Stock Is Crashing Today
December 01, 2021
From Motley Fool
2 Falling-Knife Stocks Actually Worth Buying Right Now
November 18, 2021
From Motley Fool
Adaptimmune Bullish On Meeting Endpoint For Soft Tissue Cancer Trial
November 11, 2021
Tickers
ADAP
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Adaptimmune Therapeutics plc (ADAP) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
ADAP
From Motley Fool
2 Biotech Companies That Might Be on Pfizer's Radar Right Now
November 04, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
From Motley Fool
Why Adaptimmune Therapeutics Was Sinking This Week
September 17, 2021
From Motley Fool
Looking Into Adaptimmune Therapeutics's Return On Capital Employed
September 14, 2021
Tickers
ADAP
From Benzinga
Adaptimmune Shares Encouraging Data From Solid Tumor Trial
September 13, 2021
Tickers
ADAP
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.